Hiv integrase inhibitors, pharmaceutical compositions and methods for their use

Title: Hiv integrase inhibitors, pharmaceutical compositions and methods for their use.Abstract: are described. The beta-carboline hydroxamic acid compounds and compositions containing those compounds may be used to inhibit or modulate the activity of HIV integrase enzyme and to treat HIV integrase-mediated diseases and conditions.
Beta-carboline hydroxamic acid compounds represented by formula (I) ...

You can also Monitor Keywords and Search for tracking patents relating to this Hiv integrase inhibitors, pharmaceutical compositions and methods for their use patent application.

###

How KEYWORD MONITOR works... a FREEservice from FreshPatents1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored. 3. Each week you receive an email with patent applications related to your keywords. Start now! - Receive info on patent apps like Hiv integrase inhibitors, pharmaceutical compositions and methods for their use or other areas of interest.###

Thank you for viewing the Hiv integrase inhibitors, pharmaceutical compositions and methods for their use patent info.- - -

Data source: patent applications published in the public domain by the United States Patent and Trademark Office (USPTO). Information published here is for research/educational purposes only. FreshPatents is not affiliated with the USPTO, assignee companies, inventors, law firms or other assignees. Patent applications, documents and images may contain trademarks of the respective companies/authors. FreshPatents is not responsible for the accuracy, validity or otherwise contents of these public document patent application filings. When possible a complete PDF is provided, however, in some cases the presented document/images is an abstract or sampling of the full patent application for display purposes. FreshPatents.com Terms/Support -g1-0.0924

20060608|20060122211|hiv integrase inhibitors, pharmaceutical compositions and methods for their use|are described. The beta-carboline hydroxamic acid compounds and compositions containing those compounds may be used to inhibit or modulate the activity of HIV integrase enzyme and to treat HIV integrase-mediated diseases and conditions.
Beta-carboline hydroxamic acid compounds represented by formula (I) |